Hypoxia-induced MIR-210 promoter demethylation enhances proliferation, autophagy and angiogenesis of schwannoma cells

Abstract

Hypoxia, a dominant feature in cancer occurrence and evolution, exists throughout the progression of most malignant tumors. This study focused on the mechanism of hypoxia-induced MIR-210 upregulation, and the MIR-210 functions in schwannoma. We detected microvascular density, vascular endothelial growth factor (VEGF) and MIR-210 expression levels using schwannoma tissue mciroarray. The results showed that MIR-210 expression was significantly associated with VEGF. Moreover, the cytological tests showed that hypoxia induced MIR-210 expression, while reduce ephrin-A3 expression. The bisulfate genomic sequencing PCR results showed that MIR-210 promoter region was hypermethylated in RT4-D6P2T in normoxia, while demethylated in hypoxia, and the region included the hypoxia-inducible factor-1α (HIF-1α) response element site. Cellular function research showed that hypoxia resulted in RT4-D6P2T apoptosis, higher autophage and invasion. Besides, hypoxia can affect HIF-1α/VEGF-mediated angiogenesis. To learn about the specific functions of MIR-210, we found that with MIR-210 inhibition, tumor cell apoptosis increased, autophagy and angiogenesis reduced, and the cell cycle was arrested. Hypoxia promoted MIR-210 expression through promoter demethylation, then consequently enhanced tumor cell proliferation and autophagy, increasing tumor cell angiogenesis. Thus, MIR-210 could be a potential marker for judging tumor malignancy and be taken as an effective target for clinical auxiliary treatment of neurilemmoma.